Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Breast Neoplasms 6Lung Neoplasms 3Prostatic Neoplasms 2Melanoma 2Glioma 2Thyroid Neoplasms 1Spinal Fractures 1Solitary Pulmonary Nodule 1Skin Neoplasms 1Recurrence 1Phyllodes Tumor 1Osteoporosis 1Nevus 1Neoplasms 1Multiple Pulmonary Nodules 1Lymphoma, Follicular 1Locally Advanced Pancreatic Cancer 1Liver Cirrhosis 1Inflammatory Bowel Diseases 1Hypertension, Portal 1Gynecologic Cancer 1Fibrosis 1Dysplastic Nevus Syndrome 1Disease 1Depressive Disorder, Major 1Cysts 1Colorectal Neoplasms 1Central Nervous System Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1

Interventions

Vortioxetine 1Transcranial Magnetic Stimulation 1Magnetic Resonance Spectroscopy 1Diagnostic Imaging 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Depressive Disorder, Major × Diagnostic Imaging × Clear all
NCT01718730 2019-10-22

Cortical Excitability and Inhibition in MDD

Mayo Clinic

Completed
23 enrolled
Lymphoid

Depressive Disorder, Major, Lymphoma, Follicular, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡